Gene expression profiling has shown elevated AR and reduced ERα expression in tamoxifen-resistant breast cancers, while overexpression of AR can induce tamoxifen resistance in preclinical breast cancer models.26 These findings are hypothesis-generating due to the multiplicity of comparisons in this small sample set. This evidence concerns the gene ESR1 and breast carcinoma.